Irofin®(Deferiprone) – 500 mg
Deferiprone Lipomed contains the active substance deferiprone.
Share Now
Additional Information
| Name | Irofin® |
| Description | Deferiprone Lipomed contains the active substance deferiprone, which removes excess iron from the body; it is therefore called an iron chelating agent (ATC code: V03AC02). Deferiprone Lipomed is a cost-effective generic of deferiprone. The active substance is deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one), a bidentate ligand which binds to iron in a 3:1 molar ratio. |
| Active Ingredient | Deferiprone |
| Indication | Deferiprone Lipomed monotherapy is indicated for the treatment of iron overload in patients with thalassaemia major when current chelation therapy is contraindicated or inadequate. |
| Strengths | 500 mg |
| Business Partner | Lipomed |
| Origin | Switzerland |
Related Products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.
